BioWorld - Sunday, December 22, 2024

Conferences, BioWorld Science
Conferences, BioWorld Science RSS Feed RSS

Endocrine/metabolic

Tetra-agonist peptide PTT-A enhances metabolism in obese rodents

Sep. 20, 2024
No Comments
The management of obesity and its associated comorbidities needs novel approaches for safety and efficacy. Researchers from Pep2tango Therapeutics Inc. are aiming to face this challenge by developing an approach that promotes superior weight loss through the loss of fat mass only, while preserving the muscle lean mass.
Read More
Antibodies illustration
Neurology/psychiatric

Anti-CX3CR1 antibody prevents disease severity in multiple sclerosis model

Sep. 19, 2024
No Comments
Secondary progressive multiple sclerosis (SPMS) is a chronic form of disease that occurs after relapsing-remitting MS, with a progressive disease course, and its pathogenesis remains unclear. CX3C chemokine receptor 1 (CX3CR1) is a G protein-coupled receptor that may be a useful marker of Eomes+ Th cells; the antigen has been shown to be expressed by cytotoxic Th cells and required for late-onset disease.
Read More
Endocrine/metabolic

Targeting PTP1B prevents olanzapine-induced metabolic comorbidities

Sep. 19, 2024
No Comments
Previous research has demonstrated that patients treated with the second-generation antipsychotic olanzapine (OLA) have metabolic dysfunctions and insulin resistance. Researchers from Instituto de Investigaciones Biomedicas “Alberto Sols” and collaborators investigated the impact of intraperitoneal (i.p.) OLA treatment on peripheral insulin sensitivity as well as potential effects of inhibiting the protein tyrosine phosphatase 1B (PTP1B), a negative regulator of insulin signaling.
Read More
Brain waves
Neurology/psychiatric

ECTRIMS 2024: Time for neuroprotection

Sep. 19, 2024
By Coia Dulsat
No Comments
The Annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting in Copenhagen this week is celebrating its 40th edition. In recognition of this landmark, the plenary session and opening lecture were attended by Queen Margrethe of Denmark. Afterward, the hot topic session on neuroprotective therapies set the stage for the subsequent discussions on the latest trends in the management and treatment of multiple sclerosis (MS).
Read More
Cancer

CID-078 has activity in small, non-small-cell lung cancer models

Sep. 18, 2024
No Comments
Researchers from Circle Pharma Inc. have presented preclinical data for CID-078, a novel orally bioavailable cyclin A/B Rxl macrocycle being developed for the treatment of patients with lung cancer. CID-078 was developed as a macrocycle that binds to the hydrophobic patch of cyclins A and B and blocks RxL-dependent interactions of proteins, such as that of E2F1 with cyclin A-CDK2 and Myt1 with cyclin B-CDK1.
Read More
Red blood cell infected with malaria parasites
Infection

Novartis synthesizes fast-acting intravenous agents for malaria

Sep. 18, 2024
No Comments
The increasing resistance to intravenous artemisinin therapy for malaria highlights the urgent need for new treatments that offer better patient compliance and a single-dose cure to address this global health threat. Novartis AG recently presented the discovery, development and evaluation of aminoisoquinolines as fast-acting intravenous therapeutic agents for severe malaria treatment.
Read More